How a low carb/ketogenic diet affects Parkinson's disease symptoms: a 36-week study
Trial ID: ISRCTN13221188
Interventional - Phase Unknown - No longer recruiting
This 8-week randomized crossover pilot study will investigate whether an LCHF/KD-MCT approach is a safe and feasible adjunctive treatment approach for improved health biomarkers, cognition, sleep quality, and fatigue with improved scores on commonly used surveys/scales as compared with the SAD and SAD + MCT Oil approaches, and whether an LCHF/KD can be a complementary treatment approach in PD
Conditions
Nutritional interventions for Parkinson's Disease
Eligibility
Inclusion criteria
1. Between the ages of 30-85 years
2. Live in the United States
3. Can speak, read and understand English
4. Diagnosis of PD (H-Y Stages I-IV)
5. BMI>18.5 kg/m²
6. Ability to understand and follow an LCHF/KD diet
7. Obtained permission to participate from their Primary Care Provider (PCP) or neurologist
8. Signed the informed consent and the HIPAA Release of Medical Information form
Exclusion criteria
1. Does not meet inclusion criteria
2. Persons with PD H-Y Stage V
3. Persons with unstable/uncontrolled type 2 diabetes